Wedbush Reiterates Outperform on Nuvalent, Maintains $125 Price Target
Nuvalent, Inc. Class A +0.80%
Nuvalent, Inc. Class A NUVL | 107.99 | +0.80% |
Wedbush analyst David Nierengarten reiterates Nuvalent (NASDAQ:
NUVL) with a Outperform and maintains $125 price target.
